NRXS CIK: 1933567

Neuraxis, INC

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
2.25
FY22:
2.39
FY23:
2.16
FY24:
2.32
FY25:
3.01
(positive)
Change from FY21 to FY25
millions USD
FY21:
−2.97
FY22:
−3.37
FY23:
−6.66
FY24:
−7.16
FY25:
−7.83
(positive)
Change from FY21 to FY25
millions USD
FY21:
−2.93
FY22:
−5.65
FY23:
−6.62
FY24:
−7.90
FY25:
−7.66
(positive)
Change from FY21 to FY25
millions USD
FY21:
−3.03
FY22:
−4.78
FY23:
−14.6
FY24:
−8.24
FY25:
−7.80
(positive)
Change from FY21 to FY25
millions USD
FY21:
−3.03
FY22:
−4.78
FY23:
−14.6
FY24:
−8.24
FY25:
−7.80

All amounts in millions USD FY21: figures supplemented from Twelve Data because the SEC filings do not reach back this far. Data sources:SEC EDGARTwelve Data